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Background Cerebrospinal fluid concentrations of S-100B
protein, an acidic calcium-binding protein found in astrocytes and
Schwann cells, increase after central nervous system damage.
Serum S-100B protein thus has potential as a biomedical marker
of brain cell damage. Several reports show a relation between the
severity of head injury and serum S-100B protein (S-100B) levels
in trauma patients, but there are few data about S-100B in
endogenous cerebral disease.
Objective The aim of this study is to evaluate S-100B as a marker
in endogenous encephalopathy.
Methods Serum S-100B protein concentrations (pg/ml) were
measured daily by ELISA until ICU discharge in 19 ICU patients
(12 men, seven women; age 9–80 years [mean
57.1 ± 22.8 years]) with endogenous encephalopathy. The
APACHE II score and Glasgow coma scale (GCS) were used to
assess the severity; electroencephalography (EEG) and
computerised tomography (CT) were also examined. Values are
expressed as mean ± SD. The unpaired Student’s t test, or tests
of Mann–Whitney’s U, Wilcoxon signed-rank, Kruskal–Wallis and
Pearson’s correlation coefficient were used. P < 0.05 was
considered statistically significant.
Results There were 10 survivors and nine nonsurvivors with no
significant differences in age, APACHE II score or GCS. There
was no significant difference in S-100B levels on admission
between survivors and nonsurvivors, but S-100B levels were
significantly lower in survivors than in nonsurvivors from day 1
(1129 ± 1780 vs 465,370 ± 780,293, P < 0.05) until ICU
discharge (16.5 ± 15.9 vs 231,120 ± 591,110, P < 0.05). In
survivors, S-100B levels decreased from 5 day (30.1 ± 18.5) to
discharge compared with admission levels (P < 0.05); in
nonsurvivors, there were no significant changes in S-100B
compared with admission levels. There were no correlations of
S-100B levels with APACHE II score (R = 0.3, P > 0.05) or GCS
(R = –0.1, P > 0.05), but EEG and CT abnormalities were
correlated with S-100B levels.
Conclusion Serum S-100B concentrations follow different
courses in survivors and nonsurvivors in endogenous
encephalopathy. Although similar on admission, differences in
serum S-100B protein between survivors and nonsurvivors
appeared from the first day after admission. In survivors, but not in
nonsurvivors, S-100B levels decreased until discharge. There were
also significant relationships with the severity of EEG or CT
abnormalities and S-100B levels. Serum S-100B protein could be
a useful biomedical marker for assessment of brain damage and
may predict prognosis in endogenous encephalopathy.
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Introduction Studies on patients with severe brain injury (SBI) are
few and are based on data from specialized centers. In Western
Macedonia the main reason for transferring trauma patients is SBI,
to a neurosurgeon with a travel time as long as 3 hours. Five
general hospitals serve the health service needs of a population of
301,522 inhabitants. Bodosakeio General Hospital covers a real
population of 100,000 and is the only one in the region backed by
an intensive care unit and 24-hour facilities for computerised
tomography scanning.
Objective The objective of this study was to evaluate the
incidence, distribution, clinical patterns and early outcome of SBI
patients admitted to our non-neurosurgical hospital, as a basis for
future efforts at improvements.
Methods Cases of SBI patients admitted to Bodosakeio hospital
(Glasgow Coma Scale ≤ 8) were identified retrospectively for a
23-month period (January 2002–December 2003) using data from
the District Health System of West Macedonia, the accident and
emergency unit, the hospital forms registering interhospital
transports and the intensive care unit records. Extracted data
concerned the incidence, gender distribution, age, external causes,
C–T lesions, associated injuries, early transfer and mortality at the
end of acute hospitalization. Additionally, data for the SBI
Table 1
Epidural Subdural Cranial Spinal Normal 
haematoma haematoma Contusions Brainswelling fracture fracture CT Total
Number 6 6 6 5 1 5 3 32
Male/female 3/3 5/1 5/1 4/1 1/0 2/3 2/1 22/10
Mean age (years) 28.16 37 44.16 17.4 3.5 52.2 38.33 31.53
Pediatric 1 0 0 3 1 0 1 6 (18.17%)
Mortality 2 (33.33%) 1 (16.16%) 4 (66.66%) 2 (40%) 0 0 0 9 (28.1%)
Associated injuries 2 1 1 1 0 1 1 7 (21.87%)
